449 related articles for article (PubMed ID: 19379066)
21. Combined renin-angiotensin-aldosterone system inhibition in patients with chronic heart failure secondary to left ventricular systolic dysfunction.
Gradman AH; Papademetriou V
Am Heart J; 2009 Jun; 157(6 Suppl):S17-23. PubMed ID: 19450720
[TBL] [Abstract][Full Text] [Related]
22. Optimal treatment of hypertension with diastolic heart failure.
Susic D; Frohlich ED
Heart Fail Clin; 2008 Jan; 4(1):117-24. PubMed ID: 18313629
[TBL] [Abstract][Full Text] [Related]
23. Antihypertensive drugs and the heart.
Diamond JA; Phillips RA
Minerva Med; 2005 Aug; 96(4):247-60. PubMed ID: 16179892
[TBL] [Abstract][Full Text] [Related]
24. The less familiar side of heart failure: symptomatic diastolic dysfunction.
Morris SA; Van Swol M; Udani B
J Fam Pract; 2005 Jun; 54(6):501-11. PubMed ID: 15939000
[TBL] [Abstract][Full Text] [Related]
25. Inadequate control of hypertension in US adults with cardiovascular disease comorbidities in 2003-2004.
Wong ND; Lopez VA; L'Italien G; Chen R; Kline SE; Franklin SS
Arch Intern Med; 2007 Dec; 167(22):2431-6. PubMed ID: 18071164
[TBL] [Abstract][Full Text] [Related]
26. Diagnosis and management of diastolic dysfunction and heart failure.
Satpathy C; Mishra TK; Satpathy R; Satpathy HK; Barone E
Am Fam Physician; 2006 Mar; 73(5):841-6. PubMed ID: 16529092
[TBL] [Abstract][Full Text] [Related]
27. Curriculum in cardiology: integrated diagnosis and management of diastolic heart failure.
Chinnaiyan KM; Alexander D; Maddens M; McCullough PA
Am Heart J; 2007 Feb; 153(2):189-200. PubMed ID: 17239676
[TBL] [Abstract][Full Text] [Related]
28. Nebivolol: a third-generation beta-blocker for hypertension.
Cheng JW
Clin Ther; 2009 Mar; 31(3):447-62. PubMed ID: 19393838
[TBL] [Abstract][Full Text] [Related]
29. Advances in the treatment of heart failure with a preserved ejection fraction.
Das A; Abraham S; Deswal A
Curr Opin Cardiol; 2008 May; 23(3):233-40. PubMed ID: 18382212
[TBL] [Abstract][Full Text] [Related]
30. Blood pressure reduction and renin-angiotensin system inhibition for prevention of congestive heart failure: a meta-analysis.
Verdecchia P; Angeli F; Cavallini C; Gattobigio R; Gentile G; Staessen JA; Reboldi G
Eur Heart J; 2009 Mar; 30(6):679-88. PubMed ID: 19168534
[TBL] [Abstract][Full Text] [Related]
31. Management of left ventricular diastolic heart failure: is it only blood pressure control?
Koprowski A; Gruchala M; Rynkiewicz A
Curr Opin Cardiol; 2009 Mar; 24(2):161-6. PubMed ID: 19532103
[TBL] [Abstract][Full Text] [Related]
32. Role of neurohormonal modulators in heart failure with relatively preserved systolic function.
Rapp JA; Gheorghiade M
Cardiol Clin; 2008 Feb; 26(1):23-40, vi. PubMed ID: 18312903
[TBL] [Abstract][Full Text] [Related]
33. Hypertension and cardiac failure in its various forms.
Gaddam KK; Verma A; Thompson M; Amin R; Ventura H
Med Clin North Am; 2009 May; 93(3):665-80. PubMed ID: 19427498
[TBL] [Abstract][Full Text] [Related]
34. [Systolic, diastolic and pulse pressure: therapeutic options].
Montereggi A
Ital Heart J Suppl; 2001 Apr; 2(4):375-80. PubMed ID: 19397010
[TBL] [Abstract][Full Text] [Related]
35. The Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) Heart Failure Validation Study: diagnosis and prognosis.
Einhorn PT; Davis BR; Massie BM; Cushman WC; Piller LB; Simpson LM; Levy D; Nwachuku CE; Black HR;
Am Heart J; 2007 Jan; 153(1):42-53. PubMed ID: 17174636
[TBL] [Abstract][Full Text] [Related]
36. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
Anand IS; Bishu K; Rector TS; Ishani A; Kuskowski MA; Cohn JN
Circulation; 2009 Oct; 120(16):1577-84. PubMed ID: 19805651
[TBL] [Abstract][Full Text] [Related]
37. Hypertension in children with chronic renal failure.
Lilova M
Turk J Pediatr; 2005; 47 Suppl():28-31. PubMed ID: 15884664
[TBL] [Abstract][Full Text] [Related]
38. Role of the renin-angiotensin-aldosterone system and inflammatory processes in the development and progression of diastolic dysfunction.
Sciarretta S; Paneni F; Palano F; Chin D; Tocci G; Rubattu S; Volpe M
Clin Sci (Lond); 2009 Mar; 116(6):467-77. PubMed ID: 19200056
[TBL] [Abstract][Full Text] [Related]
39. Multiple neurohumoral modulating agents in systolic dysfunction heart failure: are we lowering blood pressure too much?
Mak G; Murphy NF; Ali A; Walsh A; O'Loughlin C; Conlon C; McCaffrey D; Ledwidge M; McDonald K
J Card Fail; 2008 Sep; 14(7):555-60. PubMed ID: 18722320
[TBL] [Abstract][Full Text] [Related]
40. New insights into diastolic heart failure: role of diabetes mellitus.
Piccini JP; Klein L; Gheorghiade M; Bonow RO
Am J Med; 2004 Mar; 116 Suppl 5A():64S-75S. PubMed ID: 15019864
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
